Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

The Alabama Senate Thursday approved a bill that would require health insurance companies to cover prostate cancer screenings ...

Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...

In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a campaign by a patient and a charity. Abiraterone has been provided on the NHS ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

The PROSTATE-IQ trial uses the ArteraAI Prostate Test to personalize treatment for prostate cancer recurrence post-prostatectomy, potentially reducing hormone therapy use. The trial stratifies ...

For the first time, researchers have been able to grow, in a lab, both normal and primary cancerous prostate cells from a patient, and then implant a million of the cancer cells into a mouse to track ...